Thorne Prenatal Supplement Earns NSF Certified for Sport Certification

Thorne announced on July 29, 2026, that its Basic Prenatal supplement has become the first prenatal with a bioactive form of folate to earn NSF Certified for Sport certification, extending the company's certification program to a product category serving athletes and active women through preconception, pregnancy, and postpartum.¹

What Does the Certification Cover?

According to the company's news release, Basic Prenatal combines a set of nutrients selected for clinical relevance with delivery forms chosen for absorption, among them a bioactive folate source aimed at supporting fetal development as part of a wider nutritional package spanning the periods before, during, and after pregnancy. Thorne said each production lot undergoes screening for heavy metals such as lead, cadmium, mercury, and arsenic, with batches checked against quality benchmarks as well as California's Proposition 65 rules ahead of release. The company emphasized that the product's ingredient makeup is unchanged; what's new is that it now carries NSF Certified for Sport status, which brings additional screening for substances banned in competitive sport.

NSF Certified for Sport is widely regarded as a leading third-party certification in the supplement industry, Thorne stated, requiring products to undergo testing that verifies label claims and screens for banned substances. Amanda Frick, ND, LAc, Thorne's Senior Vice President of Medical, Clinical, and Scientific Affairs, said the certification extends standards long associated with elite athletes to prenatal nutrition.

“Performance doesn't stop when life changes,” said Dr. Frick. “Women deserve the same rigorous standards for their prenatal nutrition that elite athletes expect from every supplement they take. By bringing NSF Certified for Sport certification to Basic Prenatal, we're extending the trusted standard athletes have relied on from Thorne for years to one of the most important supplements they'll ever take – reinforcing our commitment to uncompromising quality, rigorous testing, and confidence at every stage of life.”

The certification follows the earlier 2026 launches of Perimenopause Complete, Women's Libido Boost, and Radiant Skin Complex, all of which debuted with NSF Certified for Sport status, and the company said it expects to expand its certified portfolio further later this year.

How Does This Fit Into Thorne's Athlete Partnerships and Women's Sports Investment?

The prenatal certification arrives amid a broader pattern of athlete-facing initiatives at Thorne. In July 2026, the company announced a partnership with WNBA player and Unrivaled co-founder Napheesa Collier, who had used Thorne products prior to the partnership and now serves as an athlete partner supporting its NSF Certified for Sport line. Thorne described Collier as joining an existing roster of athlete partners including Jrue Holiday, Ben Shelton, and Madison Keys, and characterized the addition as part of a broader effort to invest in women's sports and female athlete health, citing its association with Unrivaled. Thorne's Chief Growth Officer, Mary Beech, described Collier as an influential figure both as an athlete and as a business leader shaping women's sports.

The Collier partnership also builds on Thorne's May 2026 renewal with USA Artistic Swimming, in which the company agreed to supply NSF Certified for Sport supplements to elite athletes, and on an April 2026 national campaign with Misty Copeland and Lana Condor addressing perimenopause and libido, which ran alongside the launches of Perimenopause Complete and Women's Libido Boost.

What Broader Gaps Exist in Women's Health Formulation?

Separately, at the 2026 The Outlook on Women's Wellness conference, Dr. Frick delivered a keynote outlining research disparities in women's health.³ She noted that Google Scholar indexes roughly 36,000 entries on perimenopause compared with more than 350,000 on erectile dysfunction, despite an estimated 2 million U.S. women entering perimenopause and 1.3 million reaching menopause annually, with more than 1 billion women worldwide currently in some stage of the transition.

She attributed part of the data gap to the fact that NIH-sponsored trials were not required to include women until 1993, and to the roughly 23 years needed to correct misinformation stemming from early, flawed hormone replacement therapy studies. Dr. Frick called on formulators to prioritize quality-of-life outcomes alongside biomarkers and to involve women directly in R&D, ingredient validation, and educational messaging.

References

1. Thorne. Thorne's Basic Prenatal becomes the first prenatal with a bioactive form of folate to earn NSF Certified for Sport® certification. July 29, 2026. Accessed July 29, 2026. https://www.thorne.com/press-releases/thornes-basic-prenatal-becomes-first-prenatal-with-bioactive-form-of-folate-to-earn-nsf-certified-for-sport-certification
2. McEvoy E. Thorne adds WNBA athlete Napheesa Collier to roster of sports nutrition partnerships. July 21, 2026. Accessed July 29, 2026. https://www.nutritionaloutlook.com/view/thorne-wnba-napheesa-collier-sports-nutrition-partnerships
3. McEvoy E. Formulating for women: bridging clinical rigor with human experience. June 18, 2026. Accessed July 29, 2026. https://www.nutritionaloutlook.com/view/formulating-for-women-bridging-clinical-rigor-with-human-experience